FOXO1 and cancer: Additionally, PGC-1α has been implicated in modulating the NAD+/NADH balance, engaging with the AMPK–SIRT1-FOXO1 axis, and integrating mitochondrial stress responses, supporting cancer cell metabolic flexibility and resistance to therapeutic stress [42].